Chemical Biology Toolkit for DCLK1 Reveals Connection to RNA Processing

被引:18
作者
Liu, Yan [1 ,2 ]
Ferguson, Fleur M. [3 ,4 ]
Li, Lianbo [1 ,2 ]
Kuljanin, Miljan [5 ]
Mills, Caitlin E. [6 ]
Subramanian, Kartik [6 ,7 ]
Harshbarger, Wayne [1 ,2 ]
Gondi, Sudershan [1 ,2 ]
Wang, Jinhua [3 ,4 ]
Sorger, Peter K. [6 ]
Mancias, Joseph D. [5 ]
Gray, Nathanael S. [3 ,4 ]
Westover, Kenneth D. [1 ,2 ]
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA
[2] Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA
[3] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA
[4] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA
[5] Dana Farber Canc Inst, Div Radiat & Genome Stabil, Dept Radiat Oncol, Boston, MA 02115 USA
[6] Harvard Med Sch, Dept Syst Biol, Harvard Program Therapeut Sci, Lab Syst Pharmacol, Boston, MA 02115 USA
[7] Bristol Myers Squibb, 100 Binney St, Cambridge, MA 02142 USA
来源
CELL CHEMICAL BIOLOGY | 2020年 / 27卷 / 10期
关键词
DNA TOPOISOMERASE-II; TUMOR XENOGRAFT GROWTH; STEM-CELL MARKER; DOUBLECORTIN-LIKE; SELECTIVE INHIBITOR; HEPATOCELLULAR-CARCINOMA; PROTEIN; KINASE; EXPRESSION; SURVIVAL;
D O I
10.1016/j.chembiol.2020.07.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Doublecortin-like kinase 1 (DCLK1) is critical for neurogenesis, but overexpression is also observed in multiple cancers and is associated with poor prognosis. Nevertheless, the function of DCLK1 in cancer, especially the context-dependent functions, are poorly understood. We present a "toolkit'' that includes the DCLK1 inhibitor DCLK1-IN-1, a complementary DCLK1-IN-1-resistant mutation G532A, and kinase dead mutants D511N and D533N, which can be used to investigate signaling pathways regulated by DCLK1. Using a cancer cell line engineered to be DCLK1 dependent for growth and cell migration, we show that this toolkit can be used to discover associations between DCLK1 kinase activity and biological processes. In particular, we show an association between DCLK1 and RNA processing, including the identification of CDK11 as a potential substrate of DCLK1 using phosphoproteomics.
引用
收藏
页码:1229 / +
页数:16
相关论文
共 82 条
  • [21] Discovery of small molecule cancer drugs: Successes, challenges and opportunities
    Hoelder, Swen
    Clarke, Paul A.
    Workman, Paul
    [J]. MOLECULAR ONCOLOGY, 2012, 6 (02) : 155 - 176
  • [22] CDK11 complexes promote pre-mRNA splicing
    Hu, DL
    Mayeda, A
    Trembley, JH
    Lahti, JM
    Kidd, VJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (10) : 8623 - 8629
  • [23] Pancreatic Neuroendocrine Tumors and EMT Behavior Are Driven by the CSC Marker DCLK1
    Ikezono, Yu
    Koga, Hironori
    Akiba, Jun
    Abe, Mitsuhiko
    Yoshida, Takafumi
    Wada, Fumitaka
    Nakamura, Toru
    Iwamoto, Hideki
    Masuda, Atsutaka
    Sakaue, Takahiko
    Yano, Hirohisa
    Tsuruta, Osamu
    Torimura, Takuji
    [J]. MOLECULAR CANCER RESEARCH, 2017, 15 (06) : 744 - 752
  • [24] Dominant Expression of DCLK1 in Human Pancreatic Cancer Stem Cells Accelerates Tumor Invasion and Metastasis
    Ito, Hiromitsu
    Tanaka, Shinji
    Akiyama, Yoshimitsu
    Shimada, Shu
    Adikrisna, Rama
    Matsumura, Satoshi
    Aihara, Arihiro
    Mitsunori, Yusuke
    Ban, Daisuke
    Ochiai, Takanori
    Kudo, Atsushi
    Arii, Shigeki
    Yamaoka, Shoji
    Tanabe, Minoru
    [J]. PLOS ONE, 2016, 11 (01):
  • [25] The cellular thermal shift assay for evaluating drug target interactions in cells
    Jafari, Rozbeh
    Almqvist, Helena
    Axelsson, Hanna
    Ignatushchenko, Marina
    Lundback, Thomas
    Nordlund, Par
    Molina, Daniel Martinez
    [J]. NATURE PROTOCOLS, 2014, 9 (09) : 2100 - 2122
  • [26] Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis
    Johnson, Janel O.
    Pioro, Erik P.
    Boehringer, Ashley
    Chia, Ruth
    Feit, Howard
    Renton, Alan E.
    Pliner, Hannah A.
    Abramzon, Yevgeniya
    Marangi, Giuseppe
    Winborn, Brett J.
    Gibbs, J. Raphael
    Nalls, Michael A.
    Morgan, Sarah
    Shoai, Maryam
    Hardy, John
    Pittman, Alan
    Orrell, Richard W.
    Malaspina, Andrea
    Sidle, Katie C.
    Fratta, Pietro
    Harms, Matthew B.
    Baloh, Robert H.
    Pestronk, Alan
    Weihl, Conrad C.
    Rogaeva, Ekaterina
    Zinman, Lorne
    Drory, Vivian E.
    Borghero, Giuseppe
    Mora, Gabriele
    Calvo, Andrea
    Rothstein, Jeffrey D.
    Drepper, Carsten
    Sendtner, Michael
    Singleton, Andrew B.
    Taylor, J. Paul
    Cookson, Mark R.
    Restagno, Gabriella
    Sabatelli, Mario
    Bowser, Robert
    Chio, Adriano
    Traynor, Bryan J.
    [J]. NATURE NEUROSCIENCE, 2014, 17 (05) : 664 - +
  • [27] Overexpression of DCLK1 is predictive for recurrent disease in major salivary gland malignancies
    Kadletz, Lorenz
    Aumayr, Klaus
    Heiduschka, Gregor
    Schneider, Sven
    Enzenhofer, Elisabeth
    Lill, Claudia
    [J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2017, 274 (01) : 467 - 475
  • [28] Koga Hironori, 2016, Stem Cell Investig, V3, P37, DOI 10.21037/sci.2016.08.03
  • [29] DCLK1 Phosphorylates the Microtubule-Associated Protein MAP7D1 to Promote Axon Elongation in Cortical Neurons
    Koizumi, Hiroyuki
    Fujioka, Hiromi
    Togashi, Kazuya
    Thompson, James
    Yates, John R., III
    Gleeson, Joseph G.
    Emoto, Kazuo
    [J]. DEVELOPMENTAL NEUROBIOLOGY, 2017, 77 (04) : 493 - 510
  • [30] The small-molecule inhibitor BI 2536 reveals novel insights into mitotic roles of polo-like kinase 1
    Lenart, Peter
    Petronczki, Mark
    Steegmaier, Martin
    Di Fiore, Barbara
    Lipp, Jesse J.
    Hoffmann, Matthias
    Rettig, Wolfgang J.
    Kraut, Norbert
    Peters, Jan-Michael
    [J]. CURRENT BIOLOGY, 2007, 17 (04) : 304 - 315